A. Raz

4.0k total citations
67 papers, 3.4k citations indexed

About

A. Raz is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, A. Raz has authored 67 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 21 papers in Immunology and 15 papers in Oncology. Recurrent topics in A. Raz's work include Galectins and Cancer Biology (18 papers), Glycosylation and Glycoproteins Research (15 papers) and Cell Adhesion Molecules Research (10 papers). A. Raz is often cited by papers focused on Galectins and Cancer Biology (18 papers), Glycosylation and Glycoproteins Research (15 papers) and Cell Adhesion Molecules Research (10 papers). A. Raz collaborates with scholars based in United States, Israel and Japan. A. Raz's co-authors include Hidenori Inohara, Naohiro Oka, Susumu Nakahara, Victor Hogan, Steve Silletti, I. J. Fidler, Pnina Carmi, Hideomi Watanabe, Pratima Nangia‐Makker and Kazushige TAKEHANA and has published in prestigious journals such as Nature, The Journal of Cell Biology and The EMBO Journal.

In The Last Decade

A. Raz

67 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Raz United States 35 2.0k 1.5k 764 419 405 67 3.4k
Elizabeth J. Taparowsky United States 39 3.3k 1.6× 1.7k 1.1× 1.4k 1.8× 592 1.4× 444 1.1× 74 5.6k
SJ Collins United States 27 3.8k 1.9× 1.1k 0.7× 721 0.9× 384 0.9× 281 0.7× 47 5.5k
Victor Hogan United States 37 2.8k 1.4× 2.7k 1.8× 933 1.2× 410 1.0× 300 0.7× 53 4.4k
Hanne H. Rasmussen Denmark 36 3.1k 1.5× 744 0.5× 346 0.5× 402 1.0× 501 1.2× 45 4.1k
Thomas Moll United States 30 1.9k 0.9× 1.2k 0.8× 435 0.6× 348 0.8× 372 0.9× 73 3.7k
Atsushi Irie Japan 33 1.9k 1.0× 806 0.5× 515 0.7× 276 0.7× 424 1.0× 89 3.7k
Naoto Yamaguchi Japan 35 2.1k 1.1× 1.1k 0.7× 681 0.9× 320 0.8× 876 2.2× 128 3.9k
Shigeru Sakiyama Japan 34 2.4k 1.2× 634 0.4× 935 1.2× 709 1.7× 347 0.9× 124 3.8k
Véronique Baron France 33 2.0k 1.0× 1.1k 0.7× 772 1.0× 463 1.1× 313 0.8× 57 3.7k
Margit Rosner Austria 28 2.3k 1.1× 690 0.4× 710 0.9× 377 0.9× 419 1.0× 96 4.0k

Countries citing papers authored by A. Raz

Since Specialization
Citations

This map shows the geographic impact of A. Raz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Raz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Raz more than expected).

Fields of papers citing papers by A. Raz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Raz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Raz. The network helps show where A. Raz may publish in the future.

Co-authorship network of co-authors of A. Raz

This figure shows the co-authorship network connecting the top 25 collaborators of A. Raz. A scholar is included among the top collaborators of A. Raz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Raz. A. Raz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drori, Stavit, et al.. (2025). STIM-IP3R crosstalk regulates migration of breast cancer cells. The Journal of Cell Biology. 224(9). 1 indexed citations
2.
Ruth, Jason R., et al.. (2024). Autophagy is required for mammary tumor recurrence by promoting dormant tumor cell survival following therapy. Breast Cancer Research. 26(1). 143–143. 10 indexed citations
3.
Pastor, Joaquı́n, et al.. (2015). Inhibition of malignant thyroid carcinoma cell proliferation by Ras and galectin-3 inhibitors. Cell Death Discovery. 1(1). 15047–15047. 22 indexed citations
4.
Balan, Vitaly, et al.. (2013). The significance of galectin-3 as a new basal cell marker in prostate cancer. Cell Death and Disease. 4(8). e753–e753. 31 indexed citations
5.
Wang, Ying, et al.. (2012). Galectin-3 regulates p21 stability in human prostate cancer cells. Oncogene. 32(42). 5058–5065. 20 indexed citations
6.
Yanagawa, Takashi, Tatsuyoshi Funasaka, Soichi Tsutsumi, Hideomi Watanabe, & A. Raz. (2004). Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy. Endocrine Related Cancer. 11(4). 749–759. 58 indexed citations
7.
Tı́már, József, Erzsébet Rásó, Balázs Döme, et al.. (2002). Expression and function of the AMF receptor by human melanoma in experimental and clinical systems. Clinical & Experimental Metastasis. 19(3). 225–232. 22 indexed citations
8.
Yoshii, Takeharu, Hidenori Inohara, Yasuhiro Takenaka, et al.. (2001). Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. International Journal of Oncology. 18(4). 787–92. 85 indexed citations
9.
Honjo, Yuichiro, Hidenori Inohara, Shiro Akahani, et al.. (2000). Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma.. PubMed. 6(12). 4635–40. 131 indexed citations
10.
Bresalier, Robert S., N. Mazurek, Christopher K. Yunker, et al.. (1998). Modifying expression of the β-galactoside binding protein galectin-3 significantly alters the metastatic ability of human colon cancer cells. Gastroenterology. 114. A570–A570. 1 indexed citations
11.
Hirono, Yasuo, Sachio Fushida, Yutaka Yonemura, et al.. (1996). Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer. British Journal of Cancer. 74(12). 2003–2007. 50 indexed citations
12.
Raz, A., et al.. (1995). Identification of an Upstream Region That Controls the Transcription of the Human Autocrine Motility Factor Receptor. Biochemical and Biophysical Research Communications. 212(3). 727–742. 7 indexed citations
13.
Inohara, Hidenori & A. Raz. (1994). Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions. Glycoconjugate Journal. 11(6). 527–532. 138 indexed citations
14.
Inohara, Hidenori & A. Raz. (1994). Identification of Human Melanoma Cellular and Secreted Ligands for Galectin-3. Biochemical and Biophysical Research Communications. 201(3). 1366–1375. 79 indexed citations
15.
Silletti, Steve & A. Raz. (1993). Autocrine Motility Factor Is a Growth Factor. Biochemical and Biophysical Research Communications. 194(1). 446–457. 49 indexed citations
16.
Raz, A., et al.. (1989). Identification of the metastasis-associated, galactoside-binding lectin as a chimeric gene product with homology to an IgE-binding protein.. PubMed. 49(13). 3489–93. 113 indexed citations
17.
Zöller, Margot, Alexander Strubel, Günter J. Hämmerling, et al.. (1988). Interferon‐gamma treatment of B16 melanoma cells: Opposing effects for non‐adaptive and adaptive immune defense and its reflection by metastatic spread. International Journal of Cancer. 41(2). 256–266. 52 indexed citations
18.
Raz, A., Margot Zöller, & Avri Ben‐Ze'ev. (1986). Cell configuration and adhesive properties of metastasizing and non-metastasizing BSp73 rat adenocarcinoma cells. Experimental Cell Research. 162(1). 127–141. 37 indexed citations
19.
Raz, A., C D Bucana, William L. McLellan, & Isaiah J. Fidler. (1980). Distribution of membrane anionic sites on B16 melanoma variants with differing lung colonising potential. Nature. 284(5754). 363–364. 64 indexed citations
20.
Bach, D., A. Raz, & Ralph F. Goldman. (1976). The effect of hashish compounds on phospholipid phase transition. Biochimica et Biophysica Acta (BBA) - Biomembranes. 436(4). 889–894. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth J. Taparowsky Breakdown of academic impact, for papers by SJ Collins Breakdown of academic impact, for papers by Victor Hogan Breakdown of academic impact, for papers by Hanne H. Rasmussen Breakdown of academic impact, for papers by Thomas Moll Breakdown of academic impact, for papers by Atsushi Irie Breakdown of academic impact, for papers by Naoto Yamaguchi Breakdown of academic impact, for papers by Shigeru Sakiyama Breakdown of academic impact, for papers by Véronique Baron Breakdown of academic impact, for papers by Margit Rosner
Rankless by CCL
2026